Doheny Asset Management’s Novartis NVS Stock Holding History

Doheny Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,070	Closed	-$609K	–	94
2019 Q1	$609K	Buy	+7,070	New	+$568K	0.52%	56
2017 Q3	–	Sell	-4,018	Closed	-$300K	–	112
2017 Q2	$300K	Hold	4,018	–	–	0.14%	92
2017 Q1	$267K	Hold	4,018	–	–	0.12%	100
2016 Q4	$262K	Buy	+4,018	New	+$261K	0.13%	96
2016 Q1	–	Sell	-5,162	Closed	-$398K	–	107
2015 Q4	$398K	Sell	5,162 -83	-2%	-$6.59K	0.19%	77
2015 Q3	$432K	Sell	5,245 -3,934	-43%	-$350K	0.22%	73
2015 Q2	$809K	Hold	9,179	–	–	0.36%	64
2015 Q1	$811K	Hold	9,179	–	–	0.38%	61
2014 Q4	$762K	Buy	+9,179	New	+$761K	0.36%	63

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Doheny Asset Management's NVS Position: Q2 2019 in Review

Doheny Asset Management sold out of Novartis (NVS) in Q2 2019, closing a stake of 7,070 shares — an estimated $609K sold.

Doheny Asset Management first reported a position in NVS in Q4 2014 and held it in 9 quarters. The position peaked at $811K in Q1 2015. 1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2019.

Doheny Asset Management reported no remaining Novartis position as of Q2 2019 after selling out during the quarter.
Doheny Asset Management sold 7,070 Novartis shares in Q2 2019, an estimated $609K.
Doheny Asset Management first reported a position in Novartis in Q4 2014 and held it in 9 quarters.
Doheny Asset Management's Novartis position peaked at $811K in Q1 2015.
1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2019.

Based on Doheny Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.